BGT-004

N/A

Report date: 2026/03/20 20:03:07
NME

Base Information

Drug NameBGT-004
Drug Alias NameBGT-004BGT-010
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionG-protein coupled receptor 84 antagonists
TargetsG-protein coupled receptor 84
Therapy Area/IndicationsDermatitis, AtopicInflammatory Bowel DiseasesColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBojiyuan (Shanghai) Biopharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesBojiyuan (Shanghai) Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDermatitis, AtopicInflammatory Bowel DiseasesColitis, Ulcerative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A